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Abstract 
 
Given the growing complexity of health care, current global demographic and 
epidemiologic trends, adverse economic conditions in many parts of the world, and 
limited national budgets, it is increasingly difficult for policymakers and regulators to 
ensure continued access to affordable and high-quality health care. Decision makers 
must implement policies that support efficient, equitable, and sustainable health 
systems. To that end, this special issue aims to foster dialogue on the current state of 
health-care financing and some of the challenges that lie ahead for health systems. The 
objectives of this special issue are threefold: (1) to analyse trends in health-care 
financing in a range of countries with varying degrees of economic development and 
political organization; (2) to review the viability of different financing models based on 
international experiences; and (3) to examine how efficiency in health care systems can 
be achieved without sacrificing quality. The issue consists of three sections and includes 
contributions from academic experts, health-care practitioners, and members of the 
broader stakeholder community. 
 
Background 
 
In the wake of one of the most severe financial crises in recent history, resources for 
health and social care services are under threat as many member states of the 
Organisation for Economic Co-operation and Development (OECD) are cutting back on 
public spending to reduce budget deficits (Cylus et al. 2012; Reeves et al. 2014). At the 
same time, a growing number of low- and middle-income countries are investing 
heavily in health care, including statutory health insurance, in an effort to promote 
human development and economic growth (Gottret and Schieber 2006). All countries 
need to explore policy options to allocate resources efficiently, safeguard the quality of 
health care, promote prevention and lifestyle management, address the rising burden of 
chronic disease, and ensure the financial sustainability of health systems, among other 
priorities. 
 
The objectives of this special issue in Global Policy are threefold: (1) to analyse trends in 
health-care financing in a range of countries with varying degrees of economic 
development and political organization; (2) to review the viability of different financing 
models based on international experiences; and (3) to examine how efficiency in health 
care systems can be achieved without sacrificing quality. The issue consists of three 
sections and includes contributions from academic experts, health-care practitioners, 
and members of the broader stakeholder community. 
 
Section 1: Public and private models of financing health care 
 
The first section of the special issue explores the strengths and weaknesses of various 
public and private models of financing health care in the context of economic 
recessions. Angelis, Tordrup, and Kanavos open the section with a conceptual and 
empirical analysis of the epidemiologic, demographic, fiscal, macroeconomic, and 
technological pressures on public health insurance in selected OECD countries. They 
analyse the financial sustainability of these health systems over the next ten to fifteen 
years. Wouters and McKee then review the global evidence on whether private 
financing options—that is, private health insurance, medical savings accounts, and out-
of-pocket payments—are efficient and equitable, especially in times of economic crisis; 
they also consider whether these options offer patients adequate financial protection 
against unexpected health-care costs. 
 
Holland approaches the issue of health improvement during periods of austerity from a 
public health perspective. The article reviews historical precedents to outline potential 
government strategies for enhancing individual and population health. Costa Font et 
al., meanwhile, examine how selected European countries are financing long-term care 
for elderly and disabled patients—a major component of most health-care budgets. 
Spending on such care is rising rapidly in many high-income countries due to ageing 
populations and the growing burden of chronic diseases, and the authors consider 
future financing options for long-term care. Mills et al. develop a taxonomy of health-
care programmes, such as integrated care and disease management programmes. They 
investigate the role of these programmes in promoting sustainable financing and 
equitable and high-quality care.  
 
Section 2: Efficiency in health care 
 
The second section of the special issue examines aspects of efficiency in health-care 
delivery and how the use of scarce health-care resources can be optimised. Cylus et al. 
compare different ways of applying data envelopment analysis—a commonly used 
method to estimate productive efficiency—to measure health system performance. The 
methodological considerations raised in this article have implications for high-income 
countries trying to control health-care spending while still guaranteeing high-quality 
care, as well as for low- and middle-income countries trying to expand health-care 
delivery with limited budgets. Wright et al. compare the use of health technology 
assessment—defined by Luce and colleagues (2010) as “a method of evidence synthesis 
that considers evidence regarding clinical effectiveness, safety, cost-effectiveness and, 
when broadly applied, includes social, ethical, and legal aspects of the use of health 
technologies”—in England and Germany. The authors examine how health technology 
assessment practices have evolved in each country over the past two decades. They 
document, from a regulatory governance perspective, key points of convergence and 
divergence between these two European Union member states. 
 
Angelis, Kanavos, and Montibeller review priority-setting approaches in health care 
systems. They argue that multiple criteria decision analysis can provide a well-
structured, transparent, and robust method of priority setting. Kanavos et al. address 
the issue of risk and uncertainty in decision-making, with particular reference to 
medical technologies. They discuss how risk-sharing agreements can help decision 
makers manage risk and uncertainty at the time of marketing approval for new 
technologies—for example, uncertainty about the budget impact, clinical benefit, cost-
effectiveness, and/or utilisation of a new medicine. They examine how such schemes 
can help ensure that potentially cost-effective, new therapies remain affordable, and 
that new therapies do not pose a threat to the financial sustainability of health systems. 
 
Section 3: Country case studies and stakeholder perspectives 
 
The final section includes several country-specific case studies of recent health-care 
reform, as well as stakeholder assessments of current challenges facing health systems. 
Novick opens with a historical account of health-care reform in Argentina. The author 
diagnoses the key issues with the country’s health system—notably the high degree of 
fragmentation and the excessive out-of-pocket cost burden for patients—and proposes 
ways forward. Castro examines the introduction and expansion of health technology 
assessment in Colombia over the last decade. The article offers lessons for other middle-
income economies considering the use of such assessments to inform reimbursement 
and/or coverage decisions for new health technologies, particularly medicines and 
medical devices. Lim and Yang and Wu reflect on recent health-care reform in 
Singapore and rural China, respectively. The authors consider the implications of those 
reforms on equity, efficiency, financial sustainability, and other key policy outcomes. 
Muth assesses the barriers to health-care delivery in least developed countries. The 
author contends that the liberalisation of health insurance markets, alongside other 
private-sector approaches, offers an appropriate vehicle to improve delivery in 
resource-poor settings. 
 
Zawada et al. measure the burden of out-of-pocket health care spending in Denmark, 
Germany, and Poland. Equity in health care is an increasingly important consideration 
in many countries. The authors show that health expenditure is more concentrated 
among the poor in Poland than in either Denmark or Germany, although the latter two 
countries still have room for improvement. Finally, Arnaiz and Mossman et al. 
conclude the supplement by examining issues of access to new therapies in high- and 
middle-income countries from the perspectives of the pharmaceutical industry and 
patients, respectively. 
 
Conclusion 
 
Given the growing complexity of health care, current global demographic and 
epidemiologic trends, adverse economic conditions in many parts of the world, and 
limited national budgets, it is increasingly difficult for policymakers and regulators to 
ensure continued access to affordable and high-quality health care. Decision makers 
must implement policies that support efficient, equitable, and sustainable health 
systems. To that end, this issue of Global Policy aims to foster dialogue on the current 
state of health-care financing and some of the challenges that lie ahead for health 
systems. 
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